CellaVision AB

C26

Company Profile

  • Business description

    CellaVision AB is engaged in developing and selling instruments, software, and reagents for blood and body fluid analysis. The company automates parts of the sample preparation process and replaces manual microscopes with instruments based on digital image analysis technology and artificial intelligence. The solutions contribute to more effective workflows and higher quality in laboratory medicine. The product offer consists of products and solutions for standardized laboratory diagnostics and improved performance for cellular image processing and systems for digital microscopy in hematology, consisting of reagents, instruments, and supplementary software and peripheral equipment.

  • Contact

    Mobilvagen 12
    Lund22362
    SWE

    T: +46 464601600

    https://www.cellavision.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    265

Stocks News & Analysis

stocks

ASX healthcare giant rallies despite a fall in profits

Easing investor concerns and signalling a return to growth.
stocks

Weekly earnings wrap: BHP, CSL, NAB and more

Materials, banking, healthcare and retail heavyweights reveal diverging outlooks.
stocks

Chart of the Week: Our top dividend stock picks on the ASX

Highlighting key income opportunities on the ASX.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,291.9016.20-0.17%
CAC 408,501.917.45-0.09%
DAX 4026,091.3337.03-0.14%
Dow JONES (US)53,463.05119.650.22%
FTSE 10010,743.3515.310.14%
HKSE25,702.24207.170.81%
NASDAQ26,331.0941.380.16%
Nikkei 22566,073.97747.551.14%
NZX 50 Index13,943.9814.310.10%
S&P 5007,707.9816.220.21%
S&P/ASX 2009,080.3021.50-0.24%
SSE Composite Index3,910.1015.680.40%

Market Movers